vs
Side-by-side financial comparison of ANAPTYSBIO, INC (ANAB) and NOODLES & Co (NDLS). Click either name above to swap in a different company.
NOODLES & Co is the larger business by last-quarter revenue ($122.1M vs $108.2M, roughly 1.1× ANAPTYSBIO, INC). ANAPTYSBIO, INC runs the higher net margin — 45.8% vs -7.5%, a 53.3% gap on every dollar of revenue. On growth, ANAPTYSBIO, INC posted the faster year-over-year revenue change (151.1% vs -4.1%). ANAPTYSBIO, INC produced more free cash flow last quarter ($98.0M vs $-2.8M). Over the past eight quarters, ANAPTYSBIO, INC's revenue compounded faster (288.3% CAGR vs -1.2%).
AnaptysBio, Inc. is a clinical-stage biotechnology company focused on developing antibody-based immunotherapies for inflammatory diseases, immuno-oncology indications, and rare disease conditions. It primarily serves the U.S. market, advancing its innovative product candidate pipeline to address unmet medical needs via rigorous research and clinical development.
Noodles & Company is an American fast-casual restaurant that offers international and American noodle dishes in addition to soups and salads. Noodles & Company was founded in 1995 by Aaron Kennedy and is headquartered in Broomfield, Colorado. The company went public in 2013 and recorded a $457 million revenue in 2017. In mid-2022, there were 458 Noodles & Company locations across 31 states.
ANAB vs NDLS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $108.2M | $122.1M |
| Net Profit | $49.6M | $-9.2M |
| Gross Margin | — | — |
| Operating Margin | 61.8% | -5.2% |
| Net Margin | 45.8% | -7.5% |
| Revenue YoY | 151.1% | -4.1% |
| Net Profit YoY | 327.8% | 32.8% |
| EPS (diluted) | $1.64 | $-0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $108.2M | — | ||
| Q3 25 | $76.3M | $122.1M | ||
| Q2 25 | $22.3M | $123.8M | ||
| Q1 25 | $27.8M | — | ||
| Q4 24 | $43.1M | $122.8M | ||
| Q3 24 | $30.0M | $127.4M | ||
| Q2 24 | $11.0M | $121.4M | ||
| Q1 24 | $7.2M | $124.3M |
| Q4 25 | $49.6M | — | ||
| Q3 25 | $15.1M | $-9.2M | ||
| Q2 25 | $-38.6M | $-9.1M | ||
| Q1 25 | $-39.3M | — | ||
| Q4 24 | $-21.8M | $-6.8M | ||
| Q3 24 | $-32.9M | $-13.6M | ||
| Q2 24 | $-46.7M | $-6.1M | ||
| Q1 24 | $-43.9M | $-6.1M |
| Q4 25 | 61.8% | — | ||
| Q3 25 | 45.5% | -5.2% | ||
| Q2 25 | -117.5% | -5.2% | ||
| Q1 25 | -99.2% | — | ||
| Q4 24 | -22.4% | -3.9% | ||
| Q3 24 | -75.8% | -9.0% | ||
| Q2 24 | -367.5% | -3.4% | ||
| Q1 24 | -587.8% | -3.7% |
| Q4 25 | 45.8% | — | ||
| Q3 25 | 19.8% | -7.5% | ||
| Q2 25 | -173.5% | -7.3% | ||
| Q1 25 | -141.6% | — | ||
| Q4 24 | -50.5% | -5.5% | ||
| Q3 24 | -109.4% | -10.7% | ||
| Q2 24 | -425.3% | -5.1% | ||
| Q1 24 | -612.0% | -4.9% |
| Q4 25 | $1.64 | — | ||
| Q3 25 | $0.52 | $-0.20 | ||
| Q2 25 | $-1.34 | $-0.20 | ||
| Q1 25 | $-1.28 | — | ||
| Q4 24 | $-0.63 | $-0.15 | ||
| Q3 24 | $-1.14 | $-0.30 | ||
| Q2 24 | $-1.71 | $-0.14 | ||
| Q1 24 | $-1.64 | $-1.64 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $238.2M | $4.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $37.2M | $-38.9M |
| Total Assets | $364.4M | $280.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $238.2M | — | ||
| Q3 25 | $109.8M | $4.7M | ||
| Q2 25 | $44.3M | $1.4M | ||
| Q1 25 | $98.6M | — | ||
| Q4 24 | $123.1M | $3.3M | ||
| Q3 24 | $191.6M | $1.8M | ||
| Q2 24 | $71.8M | $1.3M | ||
| Q1 24 | $53.7M | $3.0M |
| Q4 25 | $37.2M | — | ||
| Q3 25 | $-29.4M | $-38.9M | ||
| Q2 25 | $-44.7M | $-13.9M | ||
| Q1 25 | $34.0M | — | ||
| Q4 24 | $70.9M | $3.7M | ||
| Q3 24 | $84.4M | $9.6M | ||
| Q2 24 | $9.9M | $21.9M | ||
| Q1 24 | $47.8M | $27.2M |
| Q4 25 | $364.4M | — | ||
| Q3 25 | $353.1M | $280.6M | ||
| Q2 25 | $335.3M | $319.4M | ||
| Q1 25 | $422.1M | — | ||
| Q4 24 | $483.8M | $340.5M | ||
| Q3 24 | $493.4M | $346.3M | ||
| Q2 24 | $427.4M | $360.4M | ||
| Q1 24 | $405.8M | $368.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $98.0M | $4.3M |
| Free Cash FlowOCF − Capex | $98.0M | $-2.8M |
| FCF MarginFCF / Revenue | 90.5% | -2.3% |
| Capex IntensityCapex / Revenue | 0.0% | 5.8% |
| Cash ConversionOCF / Net Profit | 1.98× | — |
| TTM Free Cash FlowTrailing 4 quarters | $19.6M | $-7.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $98.0M | — | ||
| Q3 25 | $-27.4M | $4.3M | ||
| Q2 25 | $-40.2M | $4.0M | ||
| Q1 25 | $-10.7M | — | ||
| Q4 24 | $-66.7M | $5.8M | ||
| Q3 24 | $-10.1M | $4.7M | ||
| Q2 24 | $-21.3M | $7.0M | ||
| Q1 24 | $-37.3M | $164.0K |
| Q4 25 | $98.0M | — | ||
| Q3 25 | $-27.4M | $-2.8M | ||
| Q2 25 | $-40.3M | $1.1M | ||
| Q1 25 | $-10.7M | — | ||
| Q4 24 | $-66.9M | $-1.3M | ||
| Q3 24 | $-10.1M | $-4.5M | ||
| Q2 24 | $-21.4M | $-1.6M | ||
| Q1 24 | $-37.3M | $-15.2M |
| Q4 25 | 90.5% | — | ||
| Q3 25 | -35.9% | -2.3% | ||
| Q2 25 | -180.9% | 0.9% | ||
| Q1 25 | -38.7% | — | ||
| Q4 24 | -155.3% | -1.1% | ||
| Q3 24 | -33.7% | -3.5% | ||
| Q2 24 | -194.6% | -1.4% | ||
| Q1 24 | -519.3% | -12.2% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 5.8% | ||
| Q2 25 | 0.2% | 2.4% | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.6% | 5.8% | ||
| Q3 24 | 0.1% | 7.2% | ||
| Q2 24 | 0.3% | 7.1% | ||
| Q1 24 | 0.4% | 12.3% |
| Q4 25 | 1.98× | — | ||
| Q3 25 | -1.81× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ANAB
Segment breakdown not available.
NDLS
| Food And Beverage | $119.6M | 98% |
| Franchise | $2.5M | 2% |
